Attached files

file filename
10-K - ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2010 - Vansen Pharma Inc.form10k.htm
EX-31.1 - SECTION 302 CERTIFICATION UNDER SARBANES-OXLEY ACT OF 2002 OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - Vansen Pharma Inc.exhibit31-1.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Maria Peralta, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

the Annual Report on Form 10-K of Okana Ventures, Inc. for the year ended December 31, 2010 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

   
(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Okana Ventures, Inc.

Dated: April 15, 2011

 

  /s/Maria Peralta
  Maria Peralta
  Chief Executive Officer Chief Financial Officer,
  Treasurer, Secretary and Director
  (Principal Executive Officer, Principal Financial
  Officer and Principal Accounting Officer)
  Okana Ventures, Inc.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Okana Ventures, Inc. and will be retained by Okana Ventures, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.